Armata Pharmaceuticals, Inc. Common Stock (ARMP)
EBITDA Growth
-1485.37%
TTM · Period ending:
ARMP EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-1485.37%period ending
Latest reported-1485.37%period ending
ARMP TTM EBITDA YoY % (-23.08% → -1485.37%)
Year-over-year change
High-resolution chart · PNG
ARMP ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| -1,485.3725% | |
| -2,046.7141% | |
| -2,172.6715% | |
| 2.6975% | |
| 81.8535% | |
| 118.2015% | |
| 89.5335% | |
| 45.6316% | |
| -62.9842% | |
| -77.4708% | |
| -81.6711% | |
| -80.962% | |
| -26.7044% | |
| -64.8511% | |
| -64.3326% | |
| -42.0716% | |
| -25.9231% | |
| -20.5676% | |
| -7.0881% | |
| -21.5557% | |
| -16.3507% | |
| -12.0784% | |
| -17.3998% | |
| -14.0348% | |
| -72.8738% | |
| -77.6093% | |
| -71.2532% | |
| -66.0996% | |
| -27.1112% | |
| -9.0449% | |
| -2.0036% | |
| 2.3164% | |
| 29.8221% | |
| 21.292% | |
| 25.8505% | |
| 29.5616% | |
| 3.9377% | |
| -1.3022% | |
| -36.021% | |
| -112.8019% | |
| -70.2924% | |
| -37.2201% | |
| -8.1758% | |
| -122.8802% | |
| 84.0594% | |
| 84.4172% | |
| 83.5031% | |
| 95.1072% | |
| -319.1092% | |
| -7,759.0028% | |
| 85.384% | |
| 56.2952% | |
| 26.6027% | |
| 73.128% | |
| 68.5701% | |
| 67.4884% | |
| 79.1326% | |
| -28.8239% | |
| -16.1691% | |
| -10.0187% | |
| -339.0419% | |
| -108.3645% | |
| -139.5179% | |
| -174.4523% | |
| -15.7957% | |
| -25.5597% | |
| 3.1076% | |
| -14.5146% | |
| -15.377% | |
| -109.8321% | |
| -240.4904% | |
| -39.062% | |
| -0.5362% | |
| 63.1244% | |
| 80.106% | |
| -46.7567% | |
| -264.464% | |
| -899.8214% | |
| -6,778.7766% | |
| 53.3417% | |
| 77.58% | |
| 85.8125% | |
| 90.1044% | |
| -71.5617% | |
| -113.8394% | |
| -85.0222% | |
| 41.3509% | |
| -19.6066% | |
| -1.5645% | |
| 9.8592% | |
| 56.8182% | |
| 53.0769% | |
| 55.7143% | |
| 50% | |
| -10% | |
| -3.1746% | |
| -17.6471% | |
| -26.7857% | |
| 1.6393% | |
| -16.6667% |